References
- Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20(10):973–980.
- Oxford J, Kozlov R. Antibiotic resistance – a call to arms for primary healthcare providers. Int J Clin Pract Suppl. 2013;67(180):1–3.
- WHO. European strategic action plan on antibiotic resistance [cited 2017 May 28]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/147734/wd14E_AntibioticResistance_111380.pdf
- ECDC. EARS-Net surveillance data. Summary of the latest data on antibiotic resistance in the European Union. 2016 Nov [cited 2017 May 28]. Available from: http://ecdc.europa.eu/en/eaad/antibiotics-get-informed/antibiotics-resistance-consumption/Documents/antibiotics-EARS-Net-summary-2016.pdf
- Taylor J, Hafner M, Yerushalmi E, et al. Estimating the economic costs of antimicrobial resistance: model and results. 2014 [cited 2017 May 26]. Available from: http://www.rand.org/content/dam/rand/pubs/research_reports/RR900/RR911/RAND_RR911.pdf
- Bell BG, Schellevis F, Stobberingh E, et al. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.
- Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeut Adv Drug Saf. 2014;5(6):229–241.
- Versporten A, Bolokhovets G, Ghazaryan L, et al. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 2014;14(5):381–387.
- Marković-Peković V, Grubiša N, Burger J, et al. Initiatives to reduce nonprescription sales and dispensing of antibiotics: findings and implications. J Res Pharm Pract. 2017;6(2):120–125.
- Morgan DJ, Okeke IN, Laxminarayan R, et al. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692–701.
- Hoxha I, Malaj A, Tako R, et al. Survey on how antibiotics are dispensed in community pharmacies in Albania. Int J Pharm Pharm Sci. 2015;7(7):449–450.
- Roque F, Soares S, Breitenfeld L, et al. Attitudes of community pharmacists to antibiotic dispensing and microbial resistance: a qualitative study in Portugal. Int J Clin Pharm. 2013;35(3):417–424.
- Zapata-Cachafeiro M, González-González C, Váquez-Lago JM, et al. Determinants of antibiotic dispensing without a medical prescription: a cross-sectional study in the north of Spain. J Antimicrob Chemother. 2014;69(11):3156–3160.
- Kibuule D, Kagoya HR, Godman B. Antibiotic use in acute respiratory infections in under-fives in Uganda: findings and implications. Expert Rev Anti Infect Ther. 2016;14(9):863–872.
- Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.
- Dyar OJ, Beović B, Vlahović-Palčevski V, et al. How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther. 2016;14(4):403–413.
- Ocan M, Obuku EA, Bwanga F, et al. Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries. BMC Public Health. 2015;15:742.
- WHO. The role of pharmacist in encouraging prudent use of antibiotics and averting antimicrobial resistance: a review of policy and experience [cited 2017 May 26]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0006/262815/The-role-of-pharmacist-in-encouraging-prudent-use-of-antibiotics-and-averting-antimicrobial-resistance-a-review-of-policy-and-experience-Eng.pdf?ua=1
- NHS Scotland. National therapeutic indicators 2014/2015 [cited 2017 May 27]. Available from: http://www.sehd.scot.nhs.uk/publications/DC20141201nti.pdf
- Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother. 2011;66(7):1431–1446.
- Desrosiers M, Evans GA, Keith PK, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol. 2011;40(Suppl 2):S99–S193.
- Editorial. Appropriate use of amoxycillin clavulanate. BPJ. 2011;38:28–33 [cited 2017 May 27]. Available from: http://www.bpac.org.nz/BPJ/2011/september/docs/bpj_38_amoxicillin_pages_28-33.pdf
- WHO. Antimicrobial Medicines Consumption (AMC) Network. 2017 [cited 2017 May 26]. Available from: http://www.euro.who.int/en/publications/abstracts/antimicrobial-medicines-consumption-amc-network.-amc-data-20112014-2017
- NICE. Clostridium diffificile infection: risk with broad spectrum antibiotics [cited 2017 Jun 1]. Available from: https://www.nice.org.uk/guidance/esmpb1/resources/clostridium-difficile-infection-risk-with-broadspectrum-antibiotics-1502609568697285
- Hancox JC, Hasnain M, Vieweg WV, et al. Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: a narrative review based on the study of case reports. Therapeut Adv Infect Dis. 2013;1(5):155–165.
- Dancer SJ. The problem with cephalosporins. J Antimicrob Chemother. 2001;48(4):463–478.
- GBD Diarrhoeal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the global burden of disease study 2015. Lancet Infect Dis. 2017;17(9):909–948.
- Mansoor GF, Chikvaidze P, Varkey S, et al. Quality of child healthcare at primary healthcare facilities: a national assessment of the integrated management of childhood illnesses in Afghanistan. Int J Qual Health Care. 2017;29(1):55–62.
- Edward A, Dam K, Chege J, et al. Measuring pediatric quality of care in rural clinics-a multi-country assessment-Cambodia, Guatemala, Zambia and Kenya. Int J Qual Health Care. 2016;28(5):586–593.
- GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related sustainable development goals in 188 countries: an analysis from the global burden of disease study 2016. Lancet. 2017;390(10100):1423–1459.
- WHO. WHO collaborating centre for drug statistics methodology. ATC/DDD Index [cited 2017 Jun 1]. Available from: https://www.whocc.no/
- WHO. WHO collaborating centre for drug statistics methodology. Guidelines for ATC classification and DDD assignment. 2017 [cited 2017 May 28]. Available from: https://www.whocc.no/filearchive/publications/2017_guidelines_web.pdf
- Godman B, Shrank W, Andersen M, et al. Policies to enhance prescribing efficiency in Europe: findings and future implications. Front Pharmacol. 2010;1:141.
- Moon JC, Godman B, Petzold M, et al. Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Front Pharmacol. 2014;5:219.
- Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011;66(Suppl 6):vi71–vi77.
- ECDC. Quality indicators for antibiotic consumption in the community in Europe [cited 2017 May 27]. Available from: http://ecdc.europa.eu/en/healthtopics/antimicrobial-resistance-and-consumption/antimicrobial-consumption/esac-net-database/Pages/quality-indicators-primary-care.aspx
- Godman B, Shrank W, Andersen M, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res. 2010;10(6):707–722.
- Vončina L, Strizrep T, Godman B, et al. Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future. Expert Rev Pharmacoecon Outcomes Res. 2011;11(4):469–479.
- Bennie M, Godman B, Bishop I, et al. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert Rev Pharmacoecon Outcomes Res. 2012;12(1):125–130.
- Abuelkhair M, Abdu S, Godman B, et al. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Rev Pharmacoecon Outcomes Res. 2012;12(1):115–124.
- Garuoliene K, Godman B, Gulbinovič J, et al. European countries with small populations can obtain low prices for drugs: lithuania as a case history. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):343–349.
- Fürst J, Čižman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther. 2015;13(2):279–289.
- The State Statistical Committee of the Republic of Azerbaijan [cited 2017 Jun 6]. Available from: http://www.stat.gov.az/?lang=en